VSee Health regains compliance with Nasdaq listing requirement

VSee Health (VSEE) regained compliance with Nasdaq Listing Rule 5550(b)(1). As previously disclosed, on September 2, 2025, the Company received notice from Nasdaq that its stockholders’ equity had fallen below the $2.5 million minimum required for continued listing on The Nasdaq Capital Market. Following a hearing on September 9, 2025, the Nasdaq Hearings Panel granted the Company an exception through December 1, 2025, to demonstrate compliance. The Company is pleased to report that, through a series of strategic capital transactions completed after September 30, 2025, it has successfully increased its stockholders’ equity to approximately $9.5M on a pro forma basis as of December 1, 2025. These transactions included: Full conversion of multiple outstanding convertible notes into common stock; Cash exercise and exchange of certain public warrants; and A $6M private placement of common stock with accompanying warrants completed on November 25, 2025.